E Investing India - Online Community for Investors and Traders  

Go Back   E Investing India - Online Community for Investors and Traders > Stock Markets > Initial Public Offerings - IPO Market
Read All Rules Contact Site Administrator

Initial Public Offerings - IPO Market Initial Public Offerings - IPO Market

Reply
 
Thread Tools Display Modes
  #1  
Old 20th November 2010, 07:33 PM
Member
 
Join Date: Jul 2010
Posts: 36
Rep Power: 2
mango11 is on a distinguished road
Default Claris Lifesciences IPO



Any idea about price band?

Opening on 24th Nov 10.
Reply With Quote
  #2  
Old 22nd November 2010, 03:13 PM
ashish_jain11's Avatar
Regular Member
 
Join Date: Jul 2007
Posts: 376
Rep Power: 13
ashish_jain11 has a spectacular aura aboutashish_jain11 has a spectacular aura about
Default

Quote:
Originally Posted by mango11 View Post
Any idea about price band?

Opening on 24th Nov 10.
Price range has been declared.

Price Range: 278 to 293.
Issue Open: Nov 24, 2010 - Nov 26, 2010.
Application Lot: 22 Shares.
Registrar: Link Intime India Pvt Ltd.
Issue Size: Rs. 300.00 Crore.
Listing on both NSE & BSE..
Reply With Quote
  #3  
Old 23rd November 2010, 03:46 AM
Regular Member
 
Join Date: Aug 2009
Posts: 661
Rep Power: 14
marketmover has a spectacular aura aboutmarketmover has a spectacular aura about
Default

The promoters of Claris are shady, The Handas were promoters of Core Group, their 3 drugs are banned under US FDA for contamination. Core Group simply vanished, not before heavy manipulation in the stock, hence high speculation in Claris at the time of listing cannot be ruled out, I would like to stay away from Claris. Don't know the valuation part, as I don't even want to waste time reading its RHP.
Reply With Quote
  #4  
Old 23rd November 2010, 08:27 AM
Sachin Asher
 
Join Date: Sep 2006
Location: Vadodara
Posts: 8,631
Rep Power: 383
Alchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond repute
Default

Quote:
Originally Posted by marketmover View Post
The promoters of Claris are shady, The Handas were promoters of Core Group, their 3 drugs are banned under US FDA for contamination. Core Group simply vanished, not before heavy manipulation in the stock, hence high speculation in Claris at the time of listing cannot be ruled out, I would like to stay away from Claris. Don't know the valuation part, as I don't even want to waste time reading its RHP.
The company was Core Healthcare.

The details are mentioned in the RHP.

According to RHP, Core Healthcare was promoted by Sushil Kumar Handa.

Sushil Kumar Handa was also a promoter of Claris Lifesciences.

Quote:
One of our erstwhile promoters and relative of our individual Promoter (included in our Promoter Group), Mr. Sushil Kumar Handa, the Ex-Chairman and Managing Director of the erstwhile Core Healthcare Limited, was included in the list of wilful defaulters, in his capacity as a director of such company, maintained by the Credit Information Bureau (India) Limited, until August 2010. Further, there were certain criminal investigations against him relating to alleged economic offences, being investigated by the Central Bureau of Investigation. Furthermore, there also subsist certain criminal investigations including an investigation initiated by the Anti Corruption Bureau, and offences under the Drugs and Cosmetics Act, 1940, and he was declared a proclaimed offender due to non appearance at hearings in one such instance.
Quote:
Core Healthcare Limited, a Company promoted by Mr. Sushil Kumar Handa, one of our erstwhile promoters and a relative of our individual Promoter (included in our Promoter Group), is listed on watchoutinvestors.com in relation to certain regulatory non-compliances, on account of which regulatory action and penalties have been initiated and imposed by SEBI for certain violations of securities laws, by the BSE and NSE for certain violations of the listing agreement, and by the CDSL and NSDL in relation to dematerialization requests.
Reply With Quote
  #5  
Old 23rd November 2010, 08:04 PM
Member
 
Join Date: Sep 2010
Posts: 105
Rep Power: 2
niki_baroda is on a distinguished road
Question Maximum Limit is 1 Lac or 2 Lac INR ?

Maximum Limit is 1 Lac or 2 Lac INR?

What is grey market premium/fancy?
Reply With Quote
  #6  
Old 23rd November 2010, 10:00 PM
Junior Member
 
Join Date: Nov 2010
Posts: 2
Rep Power: 0
khalid2167 is on a distinguished road
Default

Quote:
Originally Posted by niki_baroda View Post
Maximum Limit is 1 Lac or 2 Lac INR?
What is grey market premium/fancy
Maximum limit is 2 lac for retail investors.

Grey market premium is the profit you can get before listing of the share.
Reply With Quote
  #7  
Old 24th November 2010, 09:22 PM
Member
 
Join Date: Sep 2010
Posts: 105
Rep Power: 2
niki_baroda is on a distinguished road
Default First Day Only 6% Bids in RII

First Day

Total- Offered 3207577

BSE 122650

NSE 87252

Total - Demand
209902

% Subscribed 6.54
Reply With Quote
  #8  
Old 25th November 2010, 03:01 PM
Sachin Asher
 
Join Date: Sep 2006
Location: Vadodara
Posts: 8,631
Rep Power: 383
Alchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond repute
Default

The company may be able to achieve a consolidated eps of 20 for FY 2011.

(Analysts have slightly higher estimates).

At the upper end of the price band (293) the IPO discounts FY 2011 earnings 15 times.

For a generic pharma company, it is a fair price (neither cheap nor expensive).

In a bull market, such a company can trade at 17-18 times its earnings.

I would have applied for the IPO, but the Core Healthcare connection and actions taken by US FDA are two main factors why I am still undecided.
Reply With Quote
  #9  
Old 25th November 2010, 04:02 PM
Member
 
Join Date: Sep 2010
Posts: 105
Rep Power: 2
niki_baroda is on a distinguished road
Question

What are the expert opinion, shall we apply or wait for other IPO After MOIL?

After MOIL is there other attractive IPOs or it is better to go with Claris?
Reply With Quote
  #10  
Old 26th November 2010, 08:34 AM
Regular Member
 
Join Date: Nov 2007
Posts: 926
Rep Power: 97
sudhashbahu has a brilliant futuresudhashbahu has a brilliant futuresudhashbahu has a brilliant futuresudhashbahu has a brilliant futuresudhashbahu has a brilliant futuresudhashbahu has a brilliant futuresudhashbahu has a brilliant futuresudhashbahu has a brilliant futuresudhashbahu has a brilliant futuresudhashbahu has a brilliant futuresudhashbahu has a brilliant future
Default

Issue closes today.

The updates on the NSE site (as of yesterday 5:00PM) show ZERO application in QIB category and almost zero in NII Category.

Overall subscription at 0.09 times.

Looks like a super-flop.
Reply With Quote
  #11  
Old 26th November 2010, 08:40 AM
Sachin Asher
 
Join Date: Sep 2006
Location: Vadodara
Posts: 8,631
Rep Power: 383
Alchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond repute
Default

I am skipping this IPO.

This is not a time to speculate in such IPOs.

I may not get more than 1 lot in MOIL, but MOIL is virtually risk-fee and so I will put all my money in MOIL.
Reply With Quote
  #12  
Old 26th November 2010, 08:43 AM
Member
 
Join Date: Oct 2009
Posts: 129
Rep Power: 4
ssoni is on a distinguished road
Default

Given the market sentiment today, I don't think this issue will be able to subscribe.
Reply With Quote
  #13  
Old 26th November 2010, 11:34 AM
Sachin Asher
 
Join Date: Sep 2006
Location: Vadodara
Posts: 8,631
Rep Power: 383
Alchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond repute
Default

Quote:
Originally Posted by ssoni View Post
Given the market sentiment today, I don't think this issue will be able to subscribe.
It is not just the market sentiment.

The history of Claris' promoters is also weighing down on the IPO.

If it weren't for all the recent scams, the market would have ignored the governance issues related to Claris Lifesciences.
Reply With Quote
  #14  
Old 26th November 2010, 02:33 PM
Member
 
Join Date: Oct 2010
Posts: 126
Rep Power: 4
ajitpalsingh is on a distinguished road
Default

Looks like the issue won't get subscribed. Subscribed only 40% till 3 PM.
Reply With Quote
  #15  
Old 26th November 2010, 03:55 PM
Member
 
Join Date: Oct 2009
Posts: 129
Rep Power: 4
ssoni is on a distinguished road
Default

Claris Lifesciences revises IPO price band to Rs 223-248/share.

Too much .

At least from the valuation point this looks attractive now.
Reply With Quote
  #16  
Old 28th November 2010, 08:25 PM
Member
 
Join Date: Sep 2010
Posts: 105
Rep Power: 2
niki_baroda is on a distinguished road
Question

What shall we do now Experts ? After MOIL if we have surplus money than what to do ? SCI not seems attractive on valuation & others we don't know shall we go now for Claris with revised offer price?
Reply With Quote
  #17  
Old 28th November 2010, 10:15 PM
balajis's Avatar
Junior Member
 
Join Date: Oct 2010
Location: Bangalore
Posts: 25
Rep Power: 2
balajis is on a distinguished road
Default

The revised price band is 228 to 235 which is close to 25% discount on their earlier offer price. I am eager to see if the QIBs will subscribe now.
Reply With Quote
  #18  
Old 28th November 2010, 10:37 PM
Sachin Asher
 
Join Date: Sep 2006
Location: Vadodara
Posts: 8,631
Rep Power: 383
Alchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond repute
Default

Quote:
Originally Posted by balajis View Post
The revised price band is 228 to 235 which is close to 25% discount on their earlier offer price. I am eager to see if the QIBs will subscribe now.
Many companies give an under-the-table discount to QIBs to get them to subscribe to their IPOs.

These QIBs dump the shares on listing.

I will stay away from Claris unless there is strong demand in the QIB segment.

By strong demand, I mean the QIB segment getting subscribed at least 7 times.
Reply With Quote
  #19  
Old 30th November 2010, 08:31 AM
Member
 
Join Date: Aug 2010
Posts: 77
Rep Power: 2
superman is on a distinguished road
Default

Applied 1 lot for pure listing purpose.
Reply With Quote
  #20  
Old 30th November 2010, 08:44 AM
kris_mar's Avatar
Regular Member
 
Join Date: Jan 2010
Posts: 339
Rep Power: 140
kris_mar has a reputation beyond reputekris_mar has a reputation beyond reputekris_mar has a reputation beyond reputekris_mar has a reputation beyond reputekris_mar has a reputation beyond reputekris_mar has a reputation beyond reputekris_mar has a reputation beyond reputekris_mar has a reputation beyond reputekris_mar has a reputation beyond reputekris_mar has a reputation beyond reputekris_mar has a reputation beyond repute
Default

Issue is a clear AVOID given the questionable promoter pedigree, USFDA issues and bad product quality.
Reply With Quote
  #21  
Old 13th December 2010, 12:15 PM
Junior Member
 
Join Date: Dec 2010
Posts: 2
Rep Power: 0
junior is on a distinguished road
Default

@Alchemist

Considering the following facts:

1) Pathetic response for this issue.
2) Problems with USFDA.
3) Historical record for poor opening of such issues.

A lot of operators will be there shorting this stock on opening day. My personal observation for such bad IPO issues on opening is that generally they open at discount and then "dead cat bounce" comes and then it goes down that day.

Seeing all these facts what are your suggestions and views whether is it worth shorting on the listing day?

Thanks.
Reply With Quote
  #22  
Old 13th December 2010, 03:03 PM
Sachin Asher
 
Join Date: Sep 2006
Location: Vadodara
Posts: 8,631
Rep Power: 383
Alchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond repute
Default

Quote:
Originally Posted by junior View Post
My personal observation for such bad IPO issues on opening is that generally they open at discount and then "dead cat bounce" comes and then it goes down that day.
For some stocks, the bounce is much more than a "dead cat bounce".

B.S.Transcomm had to extend its IPO and lower the price range from from 257-266 TO Rs. 248-257.

The IPO was barely subscribed.

As expected, the IPO was below the IPO price in early trade.

Then the stock started to rally.

The stock closed the day at 381.25 against an IPO price of 248 - that's 53.73% above the IPO price.

My personal observation is that there is no trend in how IPOs with poor fundamentals list. Some end the day 50% above the IPO price and some 35% below the IPO price.

Only those who like to take big risks should trade such stocks on listing day.
Reply With Quote
  #23  
Old 21st December 2010, 11:35 AM
Member
 
Join Date: Sep 2010
Posts: 105
Rep Power: 2
niki_baroda is on a distinguished road
Default

Today trading approx @ 218, is this fair value, shall we buy few shares for 1 year or still wait till it go @ 200 or below?
Reply With Quote
  #24  
Old 21st December 2010, 11:58 AM
Sachin Asher
 
Join Date: Sep 2006
Location: Vadodara
Posts: 8,631
Rep Power: 383
Alchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond reputeAlchemist has a reputation beyond repute
Default

Quote:
Originally Posted by niki_baroda View Post
Today trading approx @ 218, is this fair value, shall we buy few shares for 1 year or still wait till it go @ 200 or below?
Why do you want to buy this stock?

On paper the stock looks attractive, but it comes with big risks too.

You may end up losing a lot of money in this stock, like investors did in Core Healthcare.

(See posts #3 and #4).
Reply With Quote
Reply


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are Off
Pingbacks are On
Refbacks are Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
Astec LifeSciences IPO nils_gate Initial Public Offerings - IPO Market 5 30th October 2009 11:43 AM
Nectar Lifesciences shasha Individual Stocks 1 5th May 2008 09:40 PM


All times are GMT +5.5. The time now is 03:22 PM.


Powered by vBulletin® Version 3.6.8
Copyright ©2000 - 2012, Jelsoft Enterprises Ltd.
SEO by vBSEO 3.6.0
Ad Management plugin by RedTyger